0001209191-15-066214.txt : 20150817
0001209191-15-066214.hdr.sgml : 20150817
20150817110420
ACCESSION NUMBER: 0001209191-15-066214
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150813
FILED AS OF DATE: 20150817
DATE AS OF CHANGE: 20150817
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: JUNIPER PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000821995
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 592758596
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4 LIBERTY SQUARE
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02109
BUSINESS PHONE: 617-639-1500
MAIL ADDRESS:
STREET 1: 4 LIBERTY SQUARE
STREET 2: 4TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02109
FORMER COMPANY:
FORMER CONFORMED NAME: COLUMBIA LABORATORIES INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MERRIFIELD C ANN
CENTRAL INDEX KEY: 0001247224
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-10352
FILM NUMBER: 151058119
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-08-13
0
0000821995
JUNIPER PHARMACEUTICALS INC
JNP
0001247224
MERRIFIELD C ANN
C/O JUNIPER PHARMACEUTICALS, INC.
FOUR LIBERTY SQUARE 4TH FLOOR
BOSTON
MA
02109
1
0
0
0
JNP Stock on Open Market
2015-08-13
4
P
0
1000
9.96
A
1000
D
JNP Stock on Open Market
2015-08-14
4
P
0
2000
9.87
A
3000
D
This transaction was executed in multiple trades at an average price of $9.96. The price reported above reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon further request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction were effected.
This transaction was executed in multiple trades at an average price of $9.87. The price reported above reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon further request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction were effected.
George O. Elston
2015-08-17